About: The Pomegranate: Effects on Bacteria and Viruses That Influence Human Health

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The Pomegranate: Effects on Bacteria and Viruses That Influence Human Health Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	The Pomegranate: Effects on Bacteria and Viruses That Influence Human Health
Creator	D'souza, Doris Howell, Amy
topic	covid:ce387fc60565255c55785be208ae0b6b8fbb2ed3#this
source	Medline; PMC
abstract	Pomegranates have been known for hundreds of years for their multiple health benefits, including antimicrobial activity. The recent surge in multidrug-resistant bacteria and the possibility of widespread global virus pandemics necessitate the need for additional preventative and therapeutic options to conventional drugs. Research indicates that pomegranates and their extracts may serve as natural alternatives due to their potency against a wide range of bacterial and viral pathogens. Nearly every part of the pomegranate plant has been tested for antimicrobial activities, including the fruit juice, peel, arils, flowers, and bark. Many studies have utilized pomegranate peel with success. There are various phytochemical compounds in pomegranate that have demonstrated antimicrobial activity, but most of the studies have found that ellagic acid and larger hydrolyzable tannins, such as punicalagin, have the highest activities. In some cases the combination of the pomegranate constituents offers the most benefit. The positive clinical results on pomegranate and suppression of oral bacteria are intriguing and worthy of further study. Much of the evidence for pomegranates' antibacterial and antiviral activities against foodborne pathogens and other infectious disease organisms comes from in vitro cell-based assays, necessitating further confirmation of in vivo efficacy through human clinical trials.
has issue date	2013-05-20(xsd:dateTime)
bibo:doi	10.1155/2013/606212
bibo:pmid	23762148
has license	cc-by
sha1sum (hex)	ce387fc60565255c55785be208ae0b6b8fbb2ed3
schema:url	https://doi.org/10.1155/2013/606212
resource representing a document's title	The Pomegranate: Effects on Bacteria and Viruses That Influence Human Health
has PubMed Central identifier	PMC3671682
has PubMed identifier	23762148
schema:publication	Evid Based Complement Alternat Med
resource representing a document's body	covid:ce387fc60565255c55785be208ae0b6b8fbb2ed3#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/ce387fc60565255c55785be208ae0b6b8fbb2ed3
is schema:about of	named entity 'BENEFIT' named entity 'PHYTOCHEMICAL' named entity 'PART OF' named entity 'BACTERIAL' named entity 'ORGANISMS' named entity 'MULTIPLE' named entity 'POTENCY' named entity 'VARIOUS' named entity 'ACTIVITIES' named entity 'FLOWERS' named entity 'KNOWN' named entity 'COMBINATION' named entity 'BUT' named entity 'MULTIDRUG-RESISTANT BACTERIA' named entity 'ELLAGIC ACID' named entity 'POSSIBILITY OF' named entity 'RECENT' named entity 'PANDEMICS' named entity 'EFFICACY' named entity 'SUCCESS' named entity 'BARK' named entity 'COMES' named entity 'YEARS' named entity 'OTHER INFECTIOUS DISEASE' named entity 'TESTED FOR' named entity 'RANGE' named entity 'POMEGRANATES' named entity 'MOST OF' named entity 'CONSTITUENTS' named entity 'HAVE' named entity 'GLOBAL' named entity 'INCLUDING' named entity 'DUE TO' named entity 'EFFECTS' named entity 'extracts' named entity 'pomegranates' named entity 'oral' named entity 'peel' named entity 'positive' named entity 'bacteria' named entity 'The Pomegranate' named entity 'HUMAN HEALTH' covid:arg/ce387fc60565255c55785be208ae0b6b8fbb2ed3 named entity 'RESEARCH' named entity 'ORAL BACTERIA' named entity 'LARGER' named entity 'POSITIVE' named entity 'DEMONSTRATED' named entity 'EVIDENCE FOR' named entity 'PEEL' named entity 'NEED FOR' named entity 'BACTERIA ' named entity 'IN VITRO' named entity 'SUPPRESSION' named entity 'FOODBORNE' named entity 'POMEGRANATE' named entity 'PUNICALAGIN' named entity 'ANTIMICROBIAL ACTIVITY' named entity 'ANTIVIRAL' named entity 'POMEGRANATE PLANT' named entity 'MUCH' named entity 'ANTIBACTERIAL' named entity 'ADDITIONAL' named entity 'BACTERIA ' named entity 'VIRUSES' named entity 'HUMAN' named entity 'SERVE' named entity 'WIDE' named entity 'FRUIT JUICE' named entity 'STUDIES' named entity 'CLINICAL TRIALS' named entity 'NEARLY' named entity 'CONVENTIONAL' named entity 'SURGE' named entity 'CLINICAL RESULTS' named entity 'STUDY' named entity 'CONFIRMATION OF' named entity 'CASES'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software